Dr. Richard Katz, MD, MHA, is a strategic leader in the pharmaceutical and medical technology fields, with a focus on CNS disorders, regenerative medicine, and evidence generation for drug development. He provides consulting services in the medical technology and life sciences sectors, concentrating on creating innovative and cost-effective treatments. With a strong background in regenerative medicine, he is also dedicated to promoting advancements in medical education.